Rosatom increasing Russian isotope supplies to India
ECONOMY & POLICY

Rosatom increasing Russian isotope supplies to India

Isotope - Regional Alliance JSC (a Rusatom Healthcare company) delivered the first shipment of germanium-68/gallium-68 (Ge-68/Ga-68) generators manufactured by Cyclotron CJSC (Obninsk) under the new contract with Esente Healthcare, a local medical product distributor, to the Republic of India.

According to the contract terms, Isotope JSC will supply the Indian side with 40 units of Ge-68/Ga-68 generators within a year. Previously, with the assistance of Isotope JSC, a registration certificate was obtained from the Central Drugs Standard Control Organization for the commercialisation of Ge-68/Ga-68 generators from the Russian manufacturer.

Ga-68 isotope is used in nuclear medicine to diagnose a wide range of oncological diseases using PET scanners, allowing performing more than 100,000 diagnostic procedures per year globally.

Anton Shargin, Deputy Director General for Commercial Affairs, Isotope JSC said, "The supply of germanium-68/gallium-68 generators under a contract with the distributor – Esente Healthcare – opens up new opportunities for expansion of the Rosatom State Atomic Energy Corporation presence in the Indian nuclear medicine market and will also ensure the growth of trade in isotope products between our countries”.

Isotope - Regional Alliance JSC (a Rusatom Healthcare company) delivered the first shipment of germanium-68/gallium-68 (Ge-68/Ga-68) generators manufactured by Cyclotron CJSC (Obninsk) under the new contract with Esente Healthcare, a local medical product distributor, to the Republic of India.According to the contract terms, Isotope JSC will supply the Indian side with 40 units of Ge-68/Ga-68 generators within a year. Previously, with the assistance of Isotope JSC, a registration certificate was obtained from the Central Drugs Standard Control Organization for the commercialisation of Ge-68/Ga-68 generators from the Russian manufacturer.Ga-68 isotope is used in nuclear medicine to diagnose a wide range of oncological diseases using PET scanners, allowing performing more than 100,000 diagnostic procedures per year globally.Anton Shargin, Deputy Director General for Commercial Affairs, Isotope JSC said, The supply of germanium-68/gallium-68 generators under a contract with the distributor – Esente Healthcare – opens up new opportunities for expansion of the Rosatom State Atomic Energy Corporation presence in the Indian nuclear medicine market and will also ensure the growth of trade in isotope products between our countries”.

Related Stories

Gold Stories

Next Story
Infrastructure Urban

Ingram Micro India Earns Sixth Great Place to Work Certification

Ingram Micro India has recently received its sixth consecutive Great Place to Work® certification, recognising the company’s efforts to build a workplace culture centred on trust, collaboration and employee development.The company said the recognition reflects its continued focus on strengthening organisational culture and improving employee experience. Over the past year, Ingram Micro India has worked on employee engagement, encouraging open dialogue, building leadership capabilities and expanding learning and development opportunities.As part of its “Elevate – Soar Higher” programme..

Next Story
Infrastructure Urban

Genesys International Appoints Nikhil Alulkar as CEO

Genesys International Corporation has appointed Nikhil Alulkar as Chief Executive Officer as the geospatial technology company enters its next phase of growth across enterprise, government and international markets.Alulkar will lead company-wide operations, business execution and growth. His responsibilities will include scaling Genesys’ AI-native mapping and Digital Twin platforms, expanding its enterprise and B2B presence, strengthening government and institutional relationships, and developing the operating structure required for international expansion.The appointment comes as Genesys lo..

Next Story
Real Estate

B-Right Real Estate Targets 4.7 Mn Sq Ft Mumbai Growth by 2033

B-Right Real Estate Group has outlined plans to develop approximately 4.7 million sq ft of real estate in Mumbai by 2033 as part of its long-term Vision 2033 roadmap. The company said its expansion strategy will remain focused on Mumbai, with redevelopment-led projects forming a key part of its portfolio.Founded in 2007, B-Right Real Estate has been involved in redevelopment and Slum Rehabilitation Authority (SRA) projects across Mumbai. Its Vision 2033 strategy focuses on financial discipline, governance, design and community-oriented development as it expands its project pipeline.Founder, Ch..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement